WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company ...

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...

Patients with ARDs who received RTX demonstrated impaired humoral responses to RZV, compared with healthy controls and ...

Physicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.